메뉴 건너뛰기




Volumn 33, Issue 5, 2012, Pages 619-622

Use of intravenous immunoglobulin to treat chronic bilateral otomastoiditis in the setting of rituximab induced hypogammaglobulinemia

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; CLINDAMYCIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; LINEZOLID; METRONIDAZOLE; MOXIFLOXACIN; PREDNISONE; PYRIDOSTIGMINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RITUXIMAB; VANCOMYCIN;

EID: 84865697163     PISSN: 01960709     EISSN: 1532818X     Source Type: Journal    
DOI: 10.1016/j.amjoto.2012.01.006     Document Type: Article
Times cited : (4)

References (11)
  • 1
    • 0019366831 scopus 로고
    • Chronic ear infection in the immunodeficient patient
    • C.T. Sasaki, P. Askenase, and J. Dwyer Chronic ear infection in the immunodeficient patient Arch Otolaryngol 107 1981 82
    • (1981) Arch Otolaryngol , vol.107 , pp. 82
    • Sasaki, C.T.1    Askenase, P.2    Dwyer, J.3
  • 2
    • 58149464696 scopus 로고    scopus 로고
    • A review of the current use of rituximab in autoimmune diseases
    • H. Gürcan, D. Keskin, and J. Stern A review of the current use of rituximab in autoimmune diseases. Intl Immunopharm 9 2009 10 25
    • (2009) Intl Immunopharm , vol.9 , pp. 10-25
    • Gürcan, H.1    Keskin, D.2    Stern, J.3
  • 3
    • 33746961890 scopus 로고    scopus 로고
    • Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
    • for the REFLEX Trial Group
    • S.B. Cohen, P. Emery, M.W. Greenwald for the REFLEX Trial Group Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks Arthritis Rheum 54 2006 2793 2806
    • (2006) Arthritis Rheum , vol.54 , pp. 2793-2806
    • Cohen, S.B.1    Emery, P.2    Greenwald, M.W.3
  • 4
    • 2942537697 scopus 로고    scopus 로고
    • Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis
    • J.C. Edwards, L. Szczepanski, and J. Szechinski Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis N Engl J Med 350 2004 2572 2581
    • (2004) N Engl J Med , vol.350 , pp. 2572-2581
    • Edwards, J.C.1    Szczepanski, L.2    Szechinski, J.3
  • 5
    • 78650908659 scopus 로고    scopus 로고
    • Does rituximab increase the incidence of infectious complications? A narrative review
    • T. Kelesidis, and G. Daikos Does rituximab increase the incidence of infectious complications? A narrative review Intl J Infect Dis 15 2011 e2 e16
    • (2011) Intl J Infect Dis , vol.15
    • Kelesidis, T.1    Daikos, G.2
  • 6
    • 47849109050 scopus 로고    scopus 로고
    • Fatal Pneumocystis pneumonia following rituximab administration for rheumatoid arthritis
    • L.L. Teichmann, M. Woenckhaus, and C. Vogel Fatal Pneumocystis pneumonia following rituximab administration for rheumatoid arthritis Rheumatology 47 2008 1256 1257
    • (2008) Rheumatology , vol.47 , pp. 1256-1257
    • Teichmann, L.L.1    Woenckhaus, M.2    Vogel, C.3
  • 7
    • 77749255162 scopus 로고    scopus 로고
    • Does rituximab aggravate pre-existing hypogammaglobulinaemia?
    • L. Diwakar, and S. Gorrie Does rituximab aggravate pre-existing hypogammaglobulinaemia? J Clin Pathol 63 2010 275 277
    • (2010) J Clin Pathol , vol.63 , pp. 275-277
    • Diwakar, L.1    Gorrie, S.2
  • 8
    • 16644375833 scopus 로고    scopus 로고
    • Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma
    • S.A. Miles, and M. McGratten Persistent panhypogammaglobulinemia after CHOP-rituximab for HIV-related lymphoma J Clin Oncol 23 2005 247 248
    • (2005) J Clin Oncol , vol.23 , pp. 247-248
    • Miles, S.A.1    McGratten, M.2
  • 9
    • 38149138097 scopus 로고    scopus 로고
    • The effects of rituximab on immunocompetency in patients with autoimmune disease
    • R. Looney, R. Srinivasan, and L. Calabrese The effects of rituximab on immunocompetency in patients with autoimmune disease Arthritis Rheum 58 2008 5 14
    • (2008) Arthritis Rheum , vol.58 , pp. 5-14
    • Looney, R.1    Srinivasan, R.2    Calabrese, L.3
  • 10
    • 77949673916 scopus 로고    scopus 로고
    • Long term safety of patients receiving rituximab in rheumatoid arthritis clinical trials
    • R. van Vollenhoven, and P. Emery Long term safety of patients receiving rituximab in rheumatoid arthritis clinical trials J Rheumatol 37 2010 20 30
    • (2010) J Rheumatol , vol.37 , pp. 20-30
    • Van Vollenhoven, R.1    Emery, P.2
  • 11
    • 33747273724 scopus 로고    scopus 로고
    • Common variable immune deficiency and autoimmunity
    • D. Brandt, and M. Gershwin Common variable immune deficiency and autoimmunity Autoimmun Rev 5 2006 465 470
    • (2006) Autoimmun Rev , vol.5 , pp. 465-470
    • Brandt, D.1    Gershwin, M.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.